Article

Minimization of free radical damage by metal catalysis of multivitamin/multimineral supplements.

Research & Technology Development, Melaleuca Inc, Idaho Falls, ID 83402, USA.
Nutrition Journal (Impact Factor: 2.64). 11/2010; 9:61. DOI: 10.1186/1475-2891-9-61
Source: PubMed

ABSTRACT Multivitamin/multimineral complexes are the most common dietary supplements. Unlike minerals in foods that are incorporated in bioorganic structures, minerals in dietary supplements are typically in an inorganic form. These minerals can catalyze the generation of free radicals, thereby oxidizing antioxidants during digestion. Here we examine the ability of a matrix consisting of an amino acid and non-digestible oligosaccharide (AAOS) to blunt metal-catalyzed oxidations. Monitoring of ascorbate radical generated by copper shows that ascorbate is oxidized more slowly with the AAOS matrix than with copper sulfate. Measurement of the rate of oxidation of ascorbic acid and Trolox® by catalytic metals confirmed the ability of AAOS to slow these oxidations. Similar results were observed with iron-catalyzed formation of hydroxyl radicals. When compared to traditional forms of minerals used in supplements, we conclude that the oxidative loss of antioxidants in solution at physiological pH is much slower when AAOS is present.

0 Bookmarks
 · 
81 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vitamins with antioxidant properties have the ability to act as pro-oxidants, inducing oxidative damage and oxidative stress as opposed to preventing it. While vitamin supplements are commonly consumed, the scientific evidence for their health beneficial effects is inconclusive. In fact, even harmful effects have been reported. The present study aimed to investigate and compare pro-oxidant properties of different antioxidants and vitamins commonly found in dietary supplements, at concentrations of physiological relevance, alone or in combination with metals also found in supplements. Focus was on damages related to DNA. The vitamins' chemical oxidation potencies were studied by measuring the amount of the oxidation product 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) formed from the DNA nucleoside deoxyguanosine (dG) after vitamin exposure, using a high-performance liquid chromatography system with electrochemical and ultraviolet detection. To study the vitamins' ability to cause DNA damage to cultured cells, promyelocytic leukemia cells (HL-60) were exposed to vitamins, and strand breaks, alkali-labile sites and oxidative DNA lesions, i.e. formamido pyrimidine DNA glycosylase-sensitive sites, were detected using the comet assay. Vitamins A and C chemically induced oxidation of dG, alone and in synergism with iron or copper, whereas only vitamin C and copper induced DNA damage in cultured cells. Contrary, vitamins B1, B2, B3, B6 and B12, β-carotene, folic acid, α-tocopherol, δ-tocopherol or γ-tocopherol did not induce oxidative damage to dG, while lycopene induced a weak dose-response increase. Taken together, vitamin C and copper stood out with the strongest oxidative potency, which is of potential concern since both substances are commonly found in multivitamins.
    Mutagenesis 03/2012; 27(4):511-7. · 3.50 Impact Factor
  • Source
    Oxidative Stress - Molecular Mechanisms and Biological Effects, 04/2012; , ISBN: 978-953-51-0554-1
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the present study was to investigate the status of oxidative stress in the serum of patients af-fected with cancer breast. Changes in the levels of total antioxidant capacity (TAC), uric acid, malon-dialdehyde (MDA), nitric oxide (nitrite/nitrate), cup-per and iron were measured in serum of patients af-fected by non-metastatic as well as metastatic cancer breast. Significant decrease in TAC (32.7% -37.5%), uric acid (28.1% -49.2%), MDA (20.7% -25.2%) and nitric oxide (50.4% -61.9%) were found in both groups of cancer breast patients compared to the control group. Serum Cu 2+ concentrations were sig-nificantly lower in metastatic cancer patient group compared with both control and non-metastatic can-cer groups. Fe 2+ in serum was significantly lower in patients with non-metastatic cancer compared to normal subjects and patients with metastatic cancer. Significant differences were also observed between patients with non-metastatic and metastatic cancer breast as regards serum uric acid and nitric oxide that were lower in metastatic compared with non-metastatic cancer breast.

Full-text (2 Sources)

Download
38 Downloads
Available from
May 19, 2014